Au cours du vieillissement normal et du vieillissement pathologique de type Alzheimer, des altérations olfactives surviennent. Très précoces dans la maladie d'Alzheimer, ces troubles pourraient être signe du développement de la maladie, bien avant l'apparition des signes de déclin cognitif. Il nous paraissait donc important de caractériser et de différencier de manière précise les troubles olfactifs associés au vieillissement normal de ceux associés au vieillissement pathologique et leurs corrélats cellulaires. Notre première étude a pour objectif de clarifier le vieillissement de la fonction olfactive et sa plasticité chez le rongeur. Dans ce travail, le vieillissement apparaît comme un processus complexe, qui n'est pas une simple dégradation générale de la fonction olfactive, mais un processus qui touche de manière hétérogène les différents aspects de la perception olfactive, et dont le signe le plus marquant semble être la perte de plasticité des performances olfactives, de la neurogenèse et du système noradrénergique en réponse à une stimulation. Nous montrons que la mémoire olfactive et sa modulation par l'enrichissement de l'environnement olfactif est plus sensible au vieillissement normal que la discrimination olfactive. Le fonctionnement basal (discrimination facile et mémoire à très court terme) persiste, bien que la neurogenèse soit altérée de manière drastique et cela malgré le rôle majeur des néo neurones pour la fonction olfactive chez l'animal jeune. Nos données mettent également en évidence une altération biphasique de la neurogenèse (réduction de prolifération, puis chez les animaux sénescents, une altération de la différenciation et de la survie des néo-neurones), et une réponse plastique du système noradrénergique qui persiste à âge moyen, alors que la neurogenèse ne réponds déjà plus à l'enrichissement olfactif. Ce travail apporte ainsi les bases nécessaires pour une comparaison des altérations olfactives liées à l'âge avec celles présentes dans la MA. Notre seconde étude nous a permis de confirmer l'existence de déficits olfactifs précoces chez le modèle murin APP/PS1 de maladie d'Alzheimer, ainsi que l'implication du système noradrénergique dans ces altérations. Induite par un traitement chronique au DSP4, la déplétion noradrénergique aggrave le phénotype amyloïde dans le BO, et accentue sévèrement les troubles olfactifs. Ces données contribuent à valider l'utilisation de modèle olfactif pour l'étude des altérations précoces observées dans la maladie d'Alzheimer, en combinant la déplétion noradrénergique pour modéliser les altérations observées dans la maladie humaine, et étudier les mécanismes physiopathologiques survenant dans la MA. / During normal aging and pathological aging like Alzheimer's disease appear olfactory deficits. These deficits occur very early in Alzheimer's disease and could be among the first signs of the disease. Thus, the definition, comparison of olfactory trouble appearing in normal aging versus Alzheimer's disease and their cellular correlates is a crucial step toward comprehension of the disease. The first study was aimed at clarifying olfactory function in aging and it's plasticity in normal mice. Aging appears as a very complex process, touching heterogenatly olfactory components. The major sign of aging is the lack of plasticity of olfactory performances, neurogenic processes and noradrenergic system in response to an olfactory enrichment. Our datas show that olfactory memory and it's modulation by olfactory enrichment is more sensible to aging than olfactory discrimination. Despite the strong impairment of neurogenesis in aging, and regardless to it's major role in olfactory processes in young animals, basal olfactory performances (easy discrimination and very short term memory) remains intact in aged animals. We also show that olfactory neurogenesis is impaired in a biphasic way during aging (first, reduction of proliferation, and then in senescent mice, impairment of differentiation and survival in the olfactory bulb). Noradrenergic system plasticity persists in middle aged animals, contrarily to neurogenesis which does not respond to olfactory enrichment. Thus, this work gives us the background necessary to compare olfactory deficits in normal and pathological aging. Our second study confirms that olfactory troubles occurs early in APP/PS1 mice, our Alzheimer's disease model, and confirms the implication of noradrenergic deficits. A chronic depletion in noradrenalin produced by treatments with DSP4 aggravates amyloïd deposition and olfactory deficits in our mice. These datas provide a strong support to the use of olfactory modality to study early signs of the disease, and to combine noradrenergic depletion to reproduce clinical and physiopatholocical signs of Alzheimer's disease in human.

<div>Vertebrate neurogenesis is a multistep process that coordinates complex signaling pathways and chromatin-based regulatory machinery to generate highly specialized cells (Hsieh and Zhao 2016; Urban and Guillemot 2014; Alunni and Bally-Cuif 2016; Yao and Jin 2014; Schmidt, Strahle, and Scholpp 2013). Epigenetic factors play a fundamental role in underwriting neurogenesis in part by contributing to control of gene expression in differentiating neurons. A mechanistic understanding of the epigenetic machinery underlying neurogenesis in vertebrates is necessary both to fully understand biogenesis of neural tissue in this subphylum as well as to develop effective therapeutic strategies to treat diseased or damaged neural tissue. </div><div>An example of an epigenetic factor that is important for both neuronal differentiation and disease states is CHD5, a vertebrate-specific member of the CHD family of ATP-dependent chromatin remodeling proteins. Chromodomain / Helicase / DNA-binding (CHD) proteins play a variety of roles in vertebrate development, and misregulation or loss of CHD proteins has been linked to numerous diseases (Mayes et al. 2014; Marfella and Imbalzano 2007; Bartholomew 2014). CHD5 is expressed primarily in neural tissue, where it is thought to contribute to neurogenesis, and has been strongly linked to tumor suppression (Thompson et al. 2003; Vestin and Mills 2013). Loss of CHD5 plays a significant role in development of neuroblastoma, a devastating tumor that is a leading cause of cancer-related death in children (Jiang, Stanke, and Lahti 2011; Maris and Matthay 1999). Consistent with the disease phenotype associated with loss of CHD5, reduced expression of CHD5 impairs differentiation of neuronal cells (Egan et al. 2013b). However, ablation of CHD5 in mice surprisingly resulted in no detectable defects in brain development (Li et al. 2014; Zhuang et al. 2014). A subsequent report revealed that mice conditionally ablated for CHD5 in neural tissue exhibit symptoms consistent with an autism spectrum disorder (Pisansky et al. 2017). Much remains to be learned about the role of CHD5 in these processes to clarify these observations.</div><div>Further, Chd5 is unique among the family of Chd remodelers in that it provides a biochemical basis for crosstalk between the critical epigenetic marks H3K27me3 and DNA methylation. Chd5 and the closely related remodelers Chd3 and Chd4 are all components of the Mi-2/NuRD histone deacetylase complex that plays a critical role in mediating transcriptional repression in response to DNA methylation in mammals (Allen, Wade, and Kutateladze 2013). Only CHD5 is preferentially expressed in neural tissue, however, and only Chd5 remodelers have biochemical evidence of direct interaction with H3K27me3, which plays a critical role in enabling proper expression of transcriptional programs during neurogenesis (Egan et al. 2013b). Chd5 is thus unique among CHD remodelers in that it is biochemically linked to both DNA methylation and H3K27me3 in addition to being preferentially expressed in neural tissue.</div><div>With regards to mechanism, much remains to be learned regarding how Chd5 remodelers contribute to gene expression and tumor suppression. However, the data to date do not show extensive transcript phenotypes and it is not clear how the biochemical action of CHD5 contributes to the neurological phenotypes ascribed to altered expression of CHD5. Therefore, it is critical to determine a suitable context to study the role of CHD5 in these processes. Identification of CHD5-dependent genes in neurons is likely to generate insight into how loss of CHD5 contributes to tumorigenesis, in particular with regards to development of neuroblastoma. Regulatory pathways that drive neurogenesis have been found to be extensively conserved between humans and zebrafish. Therefore, we have turned to the power of the zebrafish model system to characterize how loss of Chd5 alters brain development during embryogenesis.</div><div>Importantly zebrafish development, and neurogenesis in particular, occurs largely over the first 5-days of development. Zebrafish are born outside of the mother, which can produce large clutches of several hundred embryos per week, providing us with an accessible context to study the role of chd5, the zebrafish homolog of human CHD5. The central nervous system of the zebrafish develops rapidly, and shares many of the organization features of the mammalian brain (Kalueff, Stewart, and Gerlai 2014). In particular, neuroblastoma arises from a population of cells known as sympathetic ganglion cells that are derived from the neural crest (Pei et al. 2013). These cells are conserved in vertebrates, and several models to study how these cells transform into neuroblastoma exist in zebrafish (Zhu et al. 2017; Morrison et al. 2016; Zhu and Thomas Look 2016). However, our understanding of the mechanisms controlling ganglion cell differentiation is incomplete and requires further investigation to understand how epigenetic and transcriptional mechanisms contribute to development of these cells and how failure of these processes leads to cancer. The neural crest undergoes a series of differentiation steps to form mature sympathetic neurons that are guided by bone morphogenic protein signaling, and transcription changes (Ernsberger and Rohrer 2018). These cells express key enzymes for synthesizing dopamine and norephinephrine to control the sympathetic system throughout the central nervous system (Ernsberger and Rohrer 2018).</div><div>To address these questions about Chd5, we have used CRISPR/Cas9 to generate chd5-/- zebrafish that are protein nulls as determined by western blot. These chd5-/- fish are phenotypically indistinguishable from wild-type fish under standard growth conditions as was previously observed for mice lacking CHD5 (Zhuang et al. 2014; Li et al. 2014). By using zebrafish, we are able to perform transcriptome analyses to identify Chd5 target genes at stages much earlier than has previously been performed in mice because we can harvest large amounts of the tissue of interest from the readily accessible embryos. We have therefore undertaken RNA-seq analysis of isolated brains from wild-type and chd5-/- fish to identify chd5-dependent genes in predominantly differentiating (2-day old) and substantially differentiated (5-day old) neural tissue. These data provide a substantively different perspective from previous studies that examine the role of CHD5 in gene expression of differentiated SY-SH5Y cells (Egan et al. 2013a) or in the forebrain of 8-week-old mice (Pisansky et al. 2017). (Jiang, Stanke, and Lahti 2011). One role we identified from this data, is the promotion of development of sympathetic ganglion cells (detailed below), illuminating for the first time a role for chd5 in promoting differentiation of cells directly involved in neuroblatoma.</div><div>We observe not only extensive changes in gene expression, but also identify a novel role for Chd5 in enabling proper splicing during this critical window of neurogenesis in the zebrafish brain. We are further exploring the role of CHD5 in these processes by creating comparable cell culture-based models of loss of CHD5 to determine the conservation of molecular phenotypes observed in zebrafish. Furthermore, this model enables us to leverage the extensive biochemical tools available in cell culture to examine alterations to the chromatin that are difficult to interpret from studies of complex tissues such as the brain. </div><div>Herein I will describe the research progress we have made to understand the role of Chd5 in gene expression and splicing in zebrafish, as well as ongoing work to engineer mouse embryonic stem cells as an additional model to study the transcriptional consequences of loss of CHD5. Critically, the addition of the cell culture model will greatly enable biochemical characterization of the changes that are leading in particular to the changes in gene expression and splicing and will provide us with a context to test for a direct role of CHD5 in these processes. In addition, this thesis will detail the results from ongoing projects using the zebrafish model system, including: development of models in zebrafish to study the tumor suppressive role of Chd5, phenotypes observed using a targeted chemical-genetic screen, and advancement in developing new tools in zebrafish to engineer specific genomic modifications that will greatly expand the power of this vertebrate model.</div><div><br></div>

No description available.

Une altération du métabolisme de l'homocystéine constitue un facteur de risque pour la survenue des maladies neurodégénératives. Par ailleurs, alors que les effets délétères d'une hypoxie néonatale sévère sont bien connus, il a été récemment montré qu'un épisode hypoxique modéré exerçait une neuroprotection via une stimulation de la neurogenèse. Notre objectif fut l'étude des conséquences cérébrales d'une carence précoce en donneurs de méthyles (folates, vitamine B12) combinée ou non à une stimulation hypoxie modérée. Un modèle in vivo de rats nés de mères carencées en donneurs de méthyles fut utilisé. Il a été étudié les mécanismes impliqués dans un modèle de progéniteurs neuronaux carencés. Les résultats ont montré des atteintes de l'intégrité tissulaire et fonctionnelle de l'hippocampe et du cervelet associée à des déficits comportementaux, à différents stades de la vie chez les animaux carencés malgré le retour à une alimentation standard au sevrage. Ces perturbations sont liées aux processus épigénétiques et à l'homocystéinylation de protéines neuronales. De plus, un dimorphisme sexuel est apparu en lien avec le récepteur nucléaire ER alpha. La neurogenèse issue de l'hypoxie a engendré des conséquences bénéfiques à long terme sur le vieillissement cérébral des rats mâles, avec un maintien de l'intégrité hippocampique. Enfin, la combinaison de la carence et de l'hypoxie, a montré que le conditionnement hypoxique améliorait le devenir tissulaire et fonctionnel du cerveau des animaux carencés. Les mécanismes clés surviendraient au cours de périodes critiques de maturation des différentes structures cérébrales, soulignant l'importance des processus de la programmation foetale / The alteration of homocysteine metabolism has been shown to constitute a risk factor for neurodegenerative diseases. Furthermore, whereas deleterious effects of severe neonatal hypoxia have been well documented, it was shown that a moderate episode of hypoxia can exert a neuroprotection with neurogenesis stimulation. Our main goal was to study the consequences on the brain of an early deficiency of methyl donors (folate, vitamin B12) with or without a hypoxia-related stimulation of neurogenesis. The effects of deficiency were investigated in rats born from dams fed a deficient diet until weaning. In vitro neuroprogenitors were additionally used for the study of cell mechanisms involved. Data showed alterations of tissue integrity in the hippocampus and the cerebellum, with associated behavioural deficits at various ages, despite a return to normal diet at weaning. Brain alterations were shown to be mainly related to epigenetic mechanisms and to homocysteinylation of specific neuronal proteins. Moreover, a sexual dimorphism was depicted, with the participation of ER alpha receptor. Neurogenesis induced in germinative zones by a brief neonatal hypoxia led to long term beneficial effects on brain aging in male rats, with preserved hippocampus integrity, in terms of cell density, synaptic plasticity, and related cognitive functions. Finally, the combination of deficiency and hypoxia revealed that brain conditioning by brief neonatal hypoxia was able to improve tissular and functional brain outcome in deficient rats. The key mechanisms involved would occur at critical periods during the maturation of the various brain structures, thus highlighting the role of fetal programming.

O sistema da procineticina desempenha um papel importante na migração dos neurônios secretores de GnRH e na neurogênese do bulbo olfatório. Camundongos com ablação dos genes que codificam a procineticina 2 (PROK2) e seu receptor (PROKR2) apresentaram fenótipos semelhantes ao da síndrome de Kallmann descrita em humanos. Mutações inativadoras nos genes PROK2 e PROKR2 foram identificadas em pacientes com hipogonadismo hipogonadotrófico isolado. Com base nestes achados, investigamos a presença de alterações estruturais nos genes PROK2 e PROKR2 em 107 pacientes brasileiros (63 com síndrome de Kallmann e 47 com hipogonadismo hipogonadotrófico isolado normósmico). Cem indivíduos brasileiros que relataram desenvolvimento puberal normal foram utilizados como grupo controle. As regiões codificadoras dos genes PROK2 e PROKR2 foram amplificadas utilizando-se oligonucleotídeos intrônicos específicos, seguida de purificação enzimática e sequenciamento automático. Duas mutações no gene PROK2 foram identificadas: a mutação p.G100fsX121 em homozigose presente em dois irmãos com síndrome de Kallmann; e a mutação p.I55fsX56 em heterozigose identiificada em um paciente com HHIn. Quatro mutações foram identificadas no gene PROKR2 (p.R80C, p.Y140X, p.L173R e p.R268C) em cinco pacientes com síndrome de Kallmann e um paciente com HHIn. Essas mutações não foram encontradas no grupo controle. As mutações do tipo missense, p.R80C, p.L173R e p.R268C foram identificadas em heterozigose. Mutações nos genes FGFR1, GnRHR, KiSS-1 e GPR54 foram excluídas nesses pacientes. O paciente portador da mutação p.R268C do PROKR2 apresentou deleção dos exons 1 e 2 do gene KAL1. Adicionalmente, as mutações p.R80C e p.R268C foram identificadas em heterozigose em parentes de primeiro grau assintomáticos dos casos índices. A nova mutação p.Y140X do PROKR2, única alteração em homozigose, foi identificada em um paciente com micropênis, criptorquidia bilateral, anosmia e palato ogival. Os pais deste paciente eram portadores da mutação p.Y140X em heterozigose e relataram desenvolvimento puberal normal e ausência de anormalidades olfatórias. Estudos in vitro da nova mutação p.R80C localizada na primeira alça intracelular demonstraram que o acúmulo de fofatidil-inositol (IP), assim como a ativação da via da MAPK foram significativamente afetadas em células transfectadas com o receptor mutado em relação ao receptor selvagem, indicando que a mutação p.R80C determina uma menor atividade do receptor. Avaliação da expressão por Western blot mostrou uma diminuição na expressão do receptor mutado R80C e uma maior expressão de receptores imaturos. Esses achados sugeriram o papel crítico da arginina localizada na posição 80 na atividade normal do receptor. Em conclusão, expandimos o repertório de mutações deletérias nos genes PROK2 e PROKR2 em pacientes com hipogonadismo hipogonadotrófico isolado. A haploinsuficiência do PROKR2 não foi suficiente para causar síndrome de Kallmann ou HHIn, entretanto mutações inativadoras em homozigose nos genes PROK2 e PROKR2 foram responsáveis pelo fenótipo reprodutivo e olfatório anormal, em concordância com os estudos prévios de ablação gênica em modelos animais. Arginina localizada na posição 80 do PROKR2 desempenha um papel crucial na adequada maturação do receptor / Physiological activation of the prokineticin pathway has a critical role in olfactory bulb morphogenesis and GnRH secretion. Knock-out mice for genes that encode prokineticin 2 (PROK2) and the prokineticin receptor 2 (PROKR2) exhibited a phenotype similar to the Kallmann syndrome (KS). Inactivating mutations in PROK2 and PROKR2 have been identified in patients with isolated hypogonadotropic hypogonadism. Based on these findings, we investigated the presence of inactivating mutations of the genes PROK2 and PROKR2 in Brazilian patients with isolated hypogonadotropic hypogonadism associated or not with olfactory abnormalities and performed in vitro studies of the new identified mutations. We studied 107 patients with HH (63 with Kallmann syndrome and 44 with normosmic HH) and 100 control individuals. The coding regions of PROK2 and PROKR2 were amplified by polymerase chain reaction followed by enzymatic purification and direct automatic sequencing. In PROK2, two known frameshift mutations were identified. Two brothers with Kallmann syndrome harbored the homozygous p.G100fsX121 mutation, whereas one male with normosmic HH harbored the heterozygous p.I55fsX56 mutation. In PROKR2, four distinct mutations (p.R80C, p.Y140X, p.L173R and p.R268C) were identified in five patients with Kallmann syndrome and in one patient with normosmic HH. These mutations were not found in the control group. The p.R80C and p.R268C missense mutations were identified in heterozygous state in the HH patients and in their asymptomatic first-degree relatives. The p.L173R was also identified in heterozygous state. In addition, no mutations of FGFR1, GnRHR, KiSS-1 or GPR54 were identified in these patients. The patient with the PROKR2 mutation p.R268C also has a deletion of the exon 1 and 2 in the gene KAL1. Notably, the new nonsense mutation (p.Y140X) was identified in homozygous state in an anosmic boy with micropenis, bilateral cryptorchidism and high-arched palate. His asymptomatic parents were heterozygous for this severe defect. In vitro studies of the new mutation, p.R80C, were performed in order to access the mechanism by which this mutation could affect the activity of the PROKR2. In vitro studies showed that the amount of fofatidil-inositol (PI) and the activation of MAPK were significantly lower in cells transfected with the R80C mutant receptor than in cells transfected with the wild receptor, indicating that this variant is a loss-of-function mutation. Binding studies and Western blot showed a reduction in the expression levels of the receptor in the plasma membrane and in whole cell, respectively. Additionally, Western blot analysis of R80C PROKR2 revealed an additional smaller molecular weight band that represents the presence of immature unglycosylated receptors. The arginine 80 in ICL1 is important for post-translational processing of PROKR2. In conclusion, we expanded the repertoire of PROK2 and PROKR2 mutations in patients with HH and showed that PROKR2 haploinsufficiency is not sufficient to cause Kallmann syndrome or normosmic HH, whereas homozygous loss-of-function mutations either in PROK2 or PROKR2 are sufficient to cause disease phenotype, in accordance with the Prokr2 and Prok2 knockout mouse models. In vitro studies suggested that the arginine located at position 80 of the receptor seems to play an important role in the receptor function

A experiência vincular, entre o cuidador primário (mãe) e o bebê, no início da vida pós-natal, constitui o contexto da neurogênese, de acordo com os estudos realizados pela Neurociência do Desenvolvimento; e o fundamento do desenvolvimento emocional segundo a teoria do psicanalista Donald W. Winnicott. O objetivo desta pesquisa é aproximar as construções teóricas de autores que estudam diferentes aspectos de uma mesma realidade: as implicações da experiência vincular entre o bebê e o cuidador primário (mãe), que acontecem nas etapas iniciais do desenvolvimento humano, no processo de inter-relação psique-soma considerada a base do desenvolvimento emocional do ser humano. Essas construções pertencem a uma linha de pesquisa em neurociência do desenvolvimento e outra em psicanálise, representada pela teoria de Donald W. Winnicott, sobre os primórdios do desenvolvimento. Considerando-se que o presente trabalho é um estudo teórico-reflexivo, foi realizada uma pesquisa bibliográfica. As conclusões têm o objetivo de fundamentar um conhecimento que possa ampliar a compreensão dos fatores que interferem no desenvolvimento do ser humano, no início da vida pós-natal, que podem ser responsáveis pelo aparecimento de psicopatologias em etapas futuras do ciclo vital. Enfatizam a necessidade do desenvolvimento de estratégias de intervenção precoce na relação mãe-bebê, em programas de assistência à infância, reforçando a importância da psicologia preventiva na proteção do desenvolvimento humano. / The bonding experience between the primary carer (Mother) and the baby, at the start of the post-natal life, forms the context of neurogenesis, according to studies carried out by Developmental Neuroscience; and is also the basis of emotional development, according to the theory of psychoanalyst Donald W. Winnicott. The objective of this study is to investigate the technical constructions of authors who study different aspects of the same reality: the implications of the bonding experience between the baby and the primary carer (mother), which take place in the initial stages of human development, in the process of the interrelation between psyche and soma, which is considered to be the basis for the emotional development the human being. These constructions belong to a line of research in developmental neuroscience, and another in psychoanalysis, represented by the theory of Donald W. Winnicott on the beginnings of development. Considering that this work is a theoretical-reflective study, a bibliographic review was carried out. The conclusions seek to support a knowledge that can further understanding of the factors which influence human development, at the start of the post-natal life, and which may be responsible for the appearance of psychopathologies in future stages of the vital cycle. They also emphasize the need for the development of strategies of early intervention in the relationship between mother and baby, in infant care programs, reinforcing the importance of preventative psychology in the protection of human development.

Der Hippocampus ist eine von zwei Gehirnregionen, in der zeitlebens kontinuierlich neue Nervenzellen gebildet werden. Er spielt eine wichtige Rolle bei der Gedächtniskonsolidierung und wird mit der funktionellen Entstehung neurodegenerativer Erkrankungen in Verbindung gebracht. Strukturveränderungen im erwachsenen Gehirn, die mit einer Depression einhergehen, sind laut Literatur auf einen geringen Serotoninspiegel und reduzierte hippocampale Neurogenese zurückzuführen. Selektive Serotonin-Wiederaufnahmehemmer (SSRI) erhöhen die Serotoninkonzentration im synaptischen Spalt und üben einen positiven Effekt auf die adulte Neurogenese aus. In der vorliegenden Arbeit wird untersucht, wie Veränderungen in der Serotonin (5-HT)-Neurotransmission durch einmalige oder chronische Gaben von Fluoxetin und speziellen Agonisten und Antagonisten für die Serotoninrezeptoren 5-HT1a und 5-HT2 in der erwachsenen Maus die Proliferation und Differenzierung von neugebildeten Nervenzellen im Gyrus dentatus beeinflussen. Die Ergebnisse zeigen, dass ein konträres Agieren beider Rezeptoren zu einem ausgewogenen Serotoninspiegel führt. 5-HT1a- und 5-HT2c-Rezeptoren haben einen Einfluss auf das Überleben neugebildeter Nervenzellen, wobei sie unterschiedliche Entwicklungsstadien innerhalb der adulten Neurogenese kontrollieren. Die vorliegende Arbeit bekräftigt außerdem, dass die chronische Gabe von Fluoxetin die adulte Neurogenese steigert. / The hippocampus as one region with ongoing neurogenesis throughout life contributes to the formation of long-term memory and has also been implicated in the pathology of major depression. Studies suggest that depression might be due to decreased levels of serotonin and reduced neurogenesis in the adult brain and that the beneficial effects of selective serotonin reuptake inhibitors would require adult hippocampal neurogenesis. Here, I investigated how modulation of serotonergic neurotransmission by acute and chronic treatment with the antidepressant fluoxetine, and selective serotonin receptor agonists and antagonists in adult mice influences precursor cell activity during development. I focused on 5-HT1a and 5-HT2 receptors as major mediators of serotonin action. The present findings suggest that an opposed action of 5-HT1a and 5-HT2c receptor subtypes result in a balanced regulation of serotonin levels in the dentate gyrus. Both receptors differentially affect intermediate cell stages in adult hippocampal neurogenesis and play an important role in the survival of newly generated neurons. Furthermore, this study confirms that chronic fluoxetine treatment increases adult neurogenesis. In conclusion, the latency of onset of fluoxetine action can be explained by a balanced interplay of 5-HT1a and 5-HT2c receptor subtypes.

Les malformations du développement cortical (MDC) résultent d’altérations au niveau de différentes étapes de la corticogénèse telles que la prolifération, la migration et la différenciation neuronale et sont généralement associées à des épilepsies pharmaco-résistantes et à des déficiences intellectuelles sévères. Les causes génétiques des MDC restent encore inconnues dans de nombreux cas, nous avons donc réalisé le séquençage de l’exome entier de nombreux patients présentant des MDC et les analyses ont permis de mettre en évidence l’implication des gènes KIF2A et NEDD4L dans les MDC. Dans le cadre de ma thèse, nous proposons de focaliser sur les conséquences cellulaires et neurodéveloppementales résultant des mutations dans les gènes KIF2A et NEDD4L retrouvées chez les patients atteints de MDC. KIF2A code pour une kinésine-13 qui a pour fonction de réguler la dynamique des microtubules (MT) via son activité MT dépolymérase ATP-dépendante aux niveaux des extrémités des MT. L’approche basée sur la technique d’électroporation in utero nous a permis de mettre en évidence le rôle crucial joué par KIF2A dans la régulation de la neurogénèse, la migration neuronale et le positionnement des neurones dans le cortex. En particulier, nos données révèlent que l’expression des mutants KIF2A responsables de MDC entraîne une augmentation du nombre de cellules à l’état de progéniteurs qui est conséquente à un allongement du temps passé dans le cycle cellulaire. Nos premières données cellulaires et au cours du développement montrent que l’expression des mutants KIF2A induit des altérations dans l’intégrité du fuseau mitotique, dans la progression mitotique et également une localisation anormale de KIF2A au niveau du cil primaire. NEDD4L code pour une E3 ubiquitine ligase qui joue un rôle dans l’ubiquitination de nombreux substrats permettant la régulation de leur dégradation et de leur localisation subcellulaire. Dans un premier temps, nos données cellulaires ont montré que les mutants associées à des MDC ont une sensibilité accrue pour la dégradation par le protéasome. De plus, l’approche d’électroporation in utero a permis de montrer que l’expression des mutants NEDD4L ainsi qu’un excès de NEDD4L WT dérégulent la neurogenèse, le positionnement des neurones et le processus de translocation terminal. Des études complémentaires, incluant le traitement à la rapamycine, ont révélé qu’un excès de NEDD4L WT mène à la dérégulation des voies de signalisations mTORC1 et Dab1 tandis que l’expression des mutants est associée à une dérégulation des voies mTORC1 et Akt. L’ensemble de ces résultats renforce donc dans un premier temps l’importance des protéines liées aux MT dans le développement cortical en décrivant le rôle crucial de la kinésine KIF2A dans des mécanismes tels que la dynamique de migration neuronale et dans la régulation du cycle cellulaire des progéniteurs neuronaux. D’autre part, nous fournissons également de nouvelles données permettant de mieux comprendre le rôle critique de NEDD4L dans la régulation des voies mTOR et de leurs contributions dans le développement cortical. / Malformations of cortical development (MCD) result from alterations in different stages of corticogenesis such as proliferation, migration and neuronal differentiation, and are generally associated with drug-resistant epilepsy and severe intellectual disabilities. The genetics causes of MCD remain largely unknown, we have thus performed the whole-exome sequencing of many patients with MCD and reported the identification of multiple pathogenic missense mutations in KIF2A and NEDD4L genes. Within the frame of my thesis project, we propose to focus on the cellular and neurodevelopmental consequences resulting from KIF2A and NEDD4L mutations shown to be involved in MCD. KIF2A is a member of the kinesin-13 family, which rather than regulating cargos transport along microtubules (MT), regulates MT dynamics by depolymerizing MTs. The in utero electroporation approach allowed us to highlight the crucial role of KIF2A in the regulation neurogenesis, neuronal migration and the neuronal positioning in the cortex. Particularly, our data show that the expression of the KIF2A mutants involved in MDC lead to an increase in the number of cells in proliferative state which is a consequence of a prolonged time spent in the cell cycle. Our first cellular data and during development show that the expression of pathogenic KIF2A mutations induce alterations in the mitotic spindle integrity, in the mitotic progression and also an abnormal localization of KIF2A in the primary cilium. NEDD4L encodes a member of the NEDD4 family of HECT-type E3 ubiquitin ligases known to regulate the turnover and function of a number of proteins involved in fundamental cellular pathways and processes. Firstly, cellular and expression data showed sensitivity of MCD-associated mutants to proteasome degradation. Moreover, the in utero electroporation approach showed that PNH-related mutants and excess wild-type NEDD4L affect neurogenesis, neuronal positioning and terminal translocation. Further investigations, including rapamycin-based experiments, found differential deregulation of pathways involved. Excess wild-type NEDD4L leads to disruption of Dab1 and mTORC1 pathways, while MCD-related mutations are associated with deregulation of mTORC1 and AKT activities. Altogether, these results reinforce the importance of MT-related proteins in cortical development describing the crucial role of KIF2A kinesin in mechanisms such as neuronal migration dynamics and neuronal progenitor’s cell cycle regulation. On the other hand, we also provide new data to better understand the critical role of NEDD4L in the regulation of mTOR pathways and their contributions in cortical development.

Das erwachsene Gehirn enthält neuronale, multipotente Stammzellen, aus denen in den beiden bekannten neurogenen Regionen des Gehirn, im Hippocampus und im olfaktorischen System, neue Nervenzellen hervorgehen. Aus Transplantationsstudien und anderen Untersuchungen weiß man, daß es die zelluläre Umgebung ist, die die neurogene Permissivität und damit die Entwicklung einer reifen neuen Nervenzelle aus einer Stamm- oder Vorläuferzelle, bestimmt. Die Schlüsselfrage lautet daher: Was macht eine neurogene Region neurogen? Neurogenität ist mehr als die Präsenz von neuralen Stammzellen. Die aktivitätsabhängige Regulation adulter hippocampaler Neurogenese stellt eine physiologische, positive Modulation von Neurogenität im erwachsenen Gehirn dar. Aktivitätsabhängige Regulation adulter hippocampaler Neurogenese ist vielstufig und kein An/Aus-Phänomen. Die unterschiedlichen Stufen der Regulation unterliegen unterschiedlicher genetischer Determination und unterschiedlicher Empfindlichkeit auf aktivitätsabhängige Stimuli. Die Steuerung des Überlebens neugeborener Zellen stellt möglicherweise den entscheidenden Schritt auf dem Weg zu einem neuen Neuron dar. Die aktivitätsabhängige Selektion durch eine überlebensfördernde Wirkung rekrutiert jedoch aus einem Pool proliferierender Vorläuferzellen, die das neurogene Potential darstellen. Die subtile Regulation adulter hippocampaler Neurogenese durch funktionsabhängige Stimuli legt eine Relevanz für hippocampale Funktion, insbesondere Lern- und Gedächtnisvorgänge nahe. Entsprechend muß aber auch eine Bedeutung für hippocampale Pathologie diskutiert werden. Das Verständnis darüber, wie Neurogenität funktions- und aktivitätsabhängig modulierbar ist, ist von größter Relevanz für die Frage, ob und wie sich Neurogenese aus ruhenden neuronalen Stamm- und Vorläuferzellen auch außerhalb neurogener Regionen induzieren und in therapeutischer Absicht nutzen läßt. / The adult brain contains neuronal, multipotent stem cells. In two neurogenic regions of the adult brain, hippocampus and olfactory system, new neurons are generated from these stem cells. From transplantation studies and other investigations it is known that the cellular microenvironment provides the neurogenic permissiveness and determines the development of a mature new neuron from a stem or progenitor cell. Thus, the key question is, what defines a neurogenic region as neurogenic, if it is not the presence of neural stem cells alone. The activity-dependent regulation of adult hippocampal neurogenesis represents a physiologic and positive modulation of neurogenic permissiveness in the adult brain. Activity-dependent regulation of adult hippocampal neurogenesis occurs on multiple steps and is not an on/off phenomenon. The different levels of regulation are differentially influenced by genetic determination and different susceptibility to activity-dependent stimuli. The regulation of the survival of a newly generated cells might be the key step in the development of a new neuron. The activity-dependent recruitment of new neurons by means of a survival-promoting effect acts upon a pool of proliferating progenitor cells, which represent the neurogenic potential. The subtle regulation of adult neurogenesis by functional stimuli suggests a relevance of adult hippocampal neurogenesis for hippocampal function, in particular learning and memory. Accordingly, a potential relevance for hippocampal pathology has to be considered. Insights on how neurogenic permissiveness can be modulated in response to functional stimuli has important implications for the question, if and how neurogenesis from quiescent neuronal stem or progenitor cells can be induced inside and outside of neurogenic regions of the adult brain and can be used for therapeutic purposes.

O início da neurogênese e diferenciação neural no sistema nervoso do embrião é controlado pela expressão orquestrada de fatores de transcrição. A caracterização de novos reguladores transcricionais nestes processos é importante para o entendimento dos mecanismos responsáveis pela formação de neurônios. Neste trabalho, nós investigamos a função do fator de transcrição Scrt2 na medula espinhal do embrião de galinha. Nossos resultados indicam que Scrt2 é expresso imediatamente após a saída do ciclo celular e em conjunto com Ngn2 e NeuroM, sugerindo uma função em neurônios recém-nascidos. Para identificar potenciais alvos de Scrt2, realizamos experimentos de eletroporação in ovo no tubo neural posterior e analisamos os fenótipos transcriptômicos com RNA-Seq. Por fim, apresentamos também uma caracterização do transcriptoma do tubo neural posterior selvagem entre HH18 e HH29 (E6), provendo uma extensa base de dados de expressão gênica para futuras investigações. Com base em nossa experiência, nós discutimos o uso de RNA-Seq em diferentes abordagens experimentais. / The onset of neurogenesis and neural differentiation in the embryonic nervous system is controlled by the coordinated expression of transcription factors. Identification of novel transcriptional regulators in these processes is essential for our understanding of the mechanisms underlying neuronal differentiation. Here, we used the chick embryonic spinal cord to investigate the role of the transcription factor Scrt2. Our results indicate that Scrt2 is expressed in cells that recently exited the mitotic cycle and overlaps with Ngn2 and NeuroM, suggesting a function in newborn neurons. To identify potential gene targets of Scrt2, we performed in ovo electroporation experiments in the posterior neural tube and assessed the transcriptomic phenotypes using RNA-Seq. Finally, we also present the transcriptomic profiles of the wild-type posterior neural tube from HH18 to HH29 (E6), providing an informative gene expression database for future investigations. Based on our experience, we discuss the use of RNA-Seq in distinct experimental approaches.